Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Milger, O. Eickelberg, S. Krauss-Etschmann, S. Dehmel (Munich, Germany). LSC 2013 abstract - MicroRNA based biomarkers for early risk assessment of asthma. Eur Respir J 2013; 42: Suppl. 57, 1109

Member's Comments

No comment yet.

Related content which might interest you: Young Investigator session: MicroRNA based biomarkers for early risk assessment of asthma Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease Year: 2013 Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up Source: International Congress 2014 – Markers Year: 2014 A new observer independent method to assess therapy response in children with severe asthma based on daily lung function Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013 Asthma-associated factors - Potential predictive markers for patients stratification, personalized treatments and prevention Source: International Congress 2016 – Asthma points to ponder Year: 2016 Clinical predictive rules to identify preschool wheezers at risk for subsequent asthma: Can we rely on them? Could we improve their performance? Source: Annual Congress 2012 - Assessing and treating childhood asthma and allergy Year: 2012 Late Breaking Abstract - Validation of a tool for the assessment of disease awareness (DA) in COPD Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Comparing non-invasive cardiovascular risk assessment tools in COPD patients: Validation with CV events Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 Different definitions in childhood asthma: how dependable is the dependent variable? Source: Eur Respir J 2010; 36: 48-56 Year: 2010 Is it possible to identify phenotypes of problematic severe asthma in children using fluctuation based clustering? Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques Year: 2016 Novel proteomic biomarkers in the evaluation of childhood asthma Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Functional Respiratory Imaging as a sensitive biomarker to assess therapeutic interventions in lung diseases Source: International Congress 2015 – Functional and imaging techniques for assessing lung, airway and respiratory muscles Year: 2015 COPD related fatigue (COPD-RF) as a patient centred outcome tool in COPD: Various predictors and its correlation with other outcome parameters Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 ADEPT, airway disease endotyping for personalized treatment: Interim analysis of asthma patients Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 Introducing a new prognostic instrument for long-term mortality prediction among COPD patients - the CADOT index. Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019 Blood biomarker algorithms to guide COPD assessment and risk stratification Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017 Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Systematic review of childhood asthma prediction models Source: International Congress 2015 – Highlights in paediatric epidemiology: air pollution, asthma and primary ciliary dyskinesia Year: 2015 Predicting risk of undiagnosed COPD: development and validation of the TargetCOPD score Source: Eur Respir J, 49 (6) 1602191; 10.1183/13993003.02191-2016 Year: 2017 Monitoring asthma - state-of-the-art physiological, imaging and biomarker assessments Source: International Congress 2018 – PG1 Asthma and chronic obstructive pulmonary disease Year: 2018 Proteome fingerprints define groups with distinct clinico-pathological phenotypes in the U-BIOPRED asthma study Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016